Swiss pharma firm, Hoffman-La Roche have been dealt a major blow, with the Chennai Patent Office deciding against its patent relating to anti-viral drug Valcyte. In the post-grant opposition filed by various Indian pharma companies, the patent office ruled against Roche stating that Valcyte lacked inventive step.
